IGF1 and neoplasm: It has been hypothesized that metformin could act with both direct and indirect mechanisms, primarily decreasing glucose, IGF-1 and insulin signaling, thereby creating an unfavorable environment for tumor growth that is similar to that created by caloric restriction22,23.